Mary Cushman Spoke with WPTZ About New Research Showing Incidence of Cognitive Impairment Prediction
Mary Cushman, University Distinguished Professor and Vice Chair at University of Vermont, shared her first post on LinkedIn:
“My 1st LinkedIn post!
I was pleased to speak with WPTZ about our new research showing that circulating laboratory markers of neurodegeneration can predict the incidence of cognitive impairment over 12 years in initially healthy people.
It is amazing to me that damage to the brain can be detected in the blood, and detect pathology occurring years before cognitive problems start.
Associations were larger than I thought they’d be.
This research comes from the REGARDS Study, which we have been conducting since 2003.”
Title: Circulating Biomarkers of Neurodegeneration and Risk of Cognitive Impairment
Authors: Russell P. Sawyer, Aleena Bennett, Jessica Blair, Suzanne E. Judd, Nels Olson, Virginia J. Howard, Nicole D. Armstrong, D. Leann Long, Hyacinth I. Hyacinth, Jennifer J. Manly, Mary Cushman
Read full paper here.
Never miss the latest with Hemostasis Today.
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI